🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the makers of Tylenol, alleging the corporations withheld safety concerns that the medication presented to children's neurological development.

The court filing comes four weeks after Donald Trump publicized an unverified association between consuming Tylenol - alternatively called acetaminophen - throughout gestation and autism in children.

Paxton is suing the pharmaceutical giant, which previously sold the drug, the only pain reliever approved for expectant mothers, and Kenvue, which currently produces it.

In a statement, he stated they "betrayed America by making money from suffering and pushing pills regardless of the potential hazards."

The company says there is insufficient reliable data connecting acetaminophen to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening countless individuals to boost earnings," Paxton, a Republican, stated.

The company stated officially that it was "deeply concerned by the perpetuation of misinformation on the security of acetaminophen and the likely effects that could have on the health of women and children in America."

On its website, the company also said it had "continuously evaluated the pertinent research and there is insufficient valid information that shows a verified association between using acetaminophen and autism."

Associations acting on behalf of physicians and medical practitioners share this view.

ACOG has said acetaminophen - the primary component in acetaminophen - is a restricted selection for expectant mothers to address pain and fever, which can create significant medical dangers if ignored.

"In more than two decades of research on the use of paracetamol in pregnancy, not a single reputable study has successfully concluded that the use of paracetamol in any period of gestation causes brain development issues in young ones," the group said.

The court filing mentions latest statements from the former administration in claiming the medication is reportedly hazardous.

Last month, Trump generated worry from health experts when he instructed women during pregnancy to "fight like hell" not to consume acetaminophen when sick.

The FDA then published an announcement that medical professionals should think about restricting the usage of Tylenol, while also stating that "a direct connection" between the drug and autism in young ones has remains unverified.

Health Secretary Robert F Kennedy Jr, who supervises the Food and Drug Administration, had pledged in April to conduct "comprehensive study program" that would determine the origin of autism in a limited time.

But specialists advised that finding a unique factor of autism spectrum disorder - thought by researchers to be the consequence of a complicated interplay of genetic and environmental factors - would not be simple.

Autism is a type of permanent neurological difference and disability that influences how people perceive and interact with the world, and is recognized using doctors' observations.

In his court filing, the attorney general - a Trump ally who is running for the Senate - asserts Kenvue and J&J "deliberately disregarded and attempted to silence the research" around paracetamol and autism spectrum disorder.

This legal action seeks to make the companies "eliminate any commercial messaging" that asserts acetaminophen is reliable for women during pregnancy.

This legal action echoes the concerns of a assembly of guardians of minors with autism spectrum disorder and ADHD who filed suit against the manufacturers of Tylenol in two years ago.

Judicial authorities threw out the case, saying investigations from the plaintiffs' authorities was inconclusive.